Cellebrite DI Ltd. (CLBT)
NEUTRALFundamental
68
Price
$11.50
Market Cap
$2.84B
Part 1 · What the company is worth
Overview
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance Sheet & Liquidity
Revenue
$496M
Trailing 12 months (through 3/31/2026)
Net Income
$72M
Trailing 12 months (through 3/31/2026)
Free Cash Flow
$125M
Total Equity
$538M
Total Liabilities
$23M
Current Ratio
1.62
Interest Coverage
-
Debt/EBITDA
0.30
Earnings Per Share
Revenue & Net Income
Free Cash Flow
Income Breakdown
Historical statement
Margins over time
Debt over time
How heavy the debt is
Growth grid
Growth — Revenue
Fair Value Estimation
Fair Value
$19.57
Current Price
$11.50
Margin of Safety
+41.2%
Fair Value Range
$12.72 - $26.42
Estimation Methods
Valuation Metrics
P/E Ratio
49.22
ROE
12.4%
P/B Ratio
5.27
P/FCF
22.72
Gross Margin
83.0%
ROIC
3.8%
Profitability Radar
Value Creation (Economic Moat)
ROIC
3.8%
WACC
10.6%
ROIC − WACC
-6.7 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
Fundamental Analysis Criteria
Passed (13)
- Gross Margin 83.0%
- P/FCF 22.72
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- ROE 15.5%
- Revenue Growth 5Y 19.5%
- Analyst Consensus 93% Buy
- Earnings Surprise avg 6.8%
- PEG Ratio 0.63
- Earnings Quality (OCF/NI) 2.01
- Net Margin Trend 16.5% vs -70.5%
Failed (6)
- Price CAGR 0.81%
- ROIC 3.8%
- P/B Ratio 5.27
- CapEx intensity
- DCF valuation (Overvalued)
- Piotroski F-Score 2/9
Unavailable (8)
- EPS data insufficient
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- Return on Tangible Assets
- Low reliance on intangibles
- Price below Graham Number
- Share Dilution (missing shares data)
Piotroski F-Score
Serious financial concerns
Earnings Quality
High quality: earnings backed by cash
Share Dilution
Buying back shares. Shareholder friendly
Governance
Part 2 · The price and when to enter
This part won't tell you whether the company is worth owning: it helps you choose when to buy it, once the fundamentals have convinced you. Inside: technical analysis, potential, historical drawdowns, gamma exposure.
Latest News
Recent headlines for CLBT, sourced from Markets Gazette.